SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity

Source: Pharmacy Times articles

Subcutaneous immunoglobulin was found to elicit fewer viral infections compared with other routes of immunoglobulin replacement therapy, including intravenous immunoglobulin.
Read More